JunD Regulates Pancreatic β-Cells Function by Altering Lipid Accumulation

The impairment of pancreatic β-cells function is partly caused by lipotoxicity, which aggravates the development of type 2 diabetes mellitus. Activator Protein 1 member JunD modulates apoptosis and oxidative stress. Recently, it has been found that JunD regulates lipid metabolism in hepatocytes and cardiomyocytes. Here, we studied the role of JunD in pancreatic β-cells. The lipotoxic effects of palmitic acid on INS-1 cells were measured, and JunD small-interfering RNA was used to assess the effect of JunD in regulating lipid metabolism and insulin secretion. The results showed that palmitic acid stimulation induced the overexpression of JunD, impaired glucose-stimulated insulin secretion, and increased intracellular lipid accumulation of β-cells. Moreover, the gene expression involved in lipid metabolism (Scd1, Fabp4, Fas, Cd36, Lpl, and Plin5) was upregulated, while gene expression involved in the pancreatic β-cells function (such as Pdx1, Nkx6.1, Glut2, and Irs-2) was decreased. Gene silencing of JunD reversed the lipotoxic effects induced by PA on β-cells. These results suggested that JunD regulated the function of pancreatic β-cells by altering lipid accumulation.


INTRODUCTION
The prevalence of type 2 diabetes mellitus (T2DM) in the world is increasing yearly. Its complications, such as cardiovascular diseases, retinopathy, and nephropathy, have been imposed a heavy burden on public health (1)(2)(3). Insufficiency of insulin secretion of pancreatic b-cells and insulin resistance, due to prolonged lipotoxicity at least in part, are the basic characteristics of diabetes. Therefore, elucidating the potential mechanism of lipotoxicity on pancreatic b-cells dysfunction is crucial in the field of diabetic therapy.
Previous studies had demonstrated that T2DM could cause lipid accumulation in nonadipocytes, including hepatocytes and myocytes (4). Recent studies have indicated the existence of lipid and its associated proteins in human b cells (5,6). As far as metabolic diseases are concerned, intracellular lipid accumulation is often caused by the imbalance of fatty acid synthesis, uptake, and hydrolysis, which eventually leads to the activation of cell apoptosis. Lipid deposition in

METHODS Animals
Twenty eight-week-old male C57BL/6J mice were purchased from the Model Animal Research Center of Shandong University, Jinan, China. The mice were housed in a temperature-and the humidity-controlled environment under a 12h light:12h dark cycle. After one week of adaptive feeding, the mice were given a 60% high-fat diet (HFD) for 16 weeks, whereas the control group was fed with a normal chow diet. T2DM mice model was induced by HFD combined with STZ. The HFD mice were injected intraperitoneally with streptozocin (100mg/kg, S0130; Sigma-Aldrich) dissolved in a 50 mM citric acid buffer after fasting for 12 h, while the control mice were injected with the citric acid buffer. T2DM mice were identified as two consecutive fasting glucose ≥ 16.7 mmol/L.

Animal Procedures
Fasting blood glucose and body weight was measured once a week. The intraperitoneal glucose tolerance test (IPGTT; 2 g/kg glucose) and intraperitoneal insulin tolerance test (IPITT; 0.75 U/kg insulin) were performed 1 week after the establishment of the T2DM mice model. After glucose or insulin injection, blood glucose concentrations were measured at 0, 30, 60, 90, 120, and 180 min. The body fat mass of the mice was detected by dualenergy X-ray absorptiometry before the mice were anesthetized for euthanasia. 6 weeks after the establishment of the T2DM mice model, the mice were euthanized. Some pancreases were digested to extract islets. Other pancreases were fixed in 4% paraformaldehyde and make paraffin sections. The sections were used for TUNEL staining and immunofluorescence staining to detect the expression of insulin and glucagon.
All experimental procedures performed in this study followed the ethical guidelines for animal studies and were approved by the Institutional Animal Care and Qilu Hospital of Shandong University, China.

PA Preparation
0.08g sodium hydroxide (NaOH) was dissolved in 4ml ddH2O to prepare 500mmol/L NaOH solution. Then, 0.1923g PA was added into 1.5 mL 500mmol/L NaOH solution and dissolved in a water bath at 75°C to prepare a 500mmol/L PA solution. Next, 1g BSA without fatty acid was added into 20mL ddH2O preheated at 55°C and centrifuged at 8000rpm for 20min to prepare 5% BSA solution. Finally, 1ml PA solution was dissolved in 9ml 5% BSA solution to obtain 50mmol/L PA solution.

Cell Viability
According to the manufacturer's instructions, INS-1 cells incubated in 96-well plates were treated with different concentration of PA (0.1, 0.2, 0.4, 0.8mM), and cell viability was assessed by Cell Counting Kit-8 (CCK-8, DoJinDo, Japan) at 6, 12, 24, 36, and 48 hours. The absorbance was detected by a microplate reader at a test wavelength of 450 nm.

Small Interfering RNA (siRNA) Transfections
The sequences of small-interfering RNAs (siRNAs) targeting rats JunD were designed and synthesized by GenePharma (Shanghai, China) for RNA silencing. The sense and antisense sequences of JunD siRNA were 5′-GCAGUUCCUCUACCCUAAGTT-3′. The normal control siRNA targeted the following sequence: 5′-CUCUGAACCCUAAGGCCAATT-3′. INS-1 cells were transfected with 160 pmol of siRNA for 6-8 h via Lipofectamine 2000 transfection reagent (Invitrogen, USA), according to the manufacturer's instructions. Cells were harvested 72h later for RNA and protein.
MgSO4·7H2O, 30mM HEPES, 1% BSA) containing 25 mM glucose for an additional 1h. According to the manufacturer's protocol, insulin concentration was measured using an insulin kit (Blue Gene, Shanghai, China). Final insulin content was normalized to the protein concentration of cells.

Islet Extraction
After euthanasia, pancreases were isolated. First, each pancreas was added to 1× Hank's Balanced Salt Solution (HBSS) (CC014; Macgene) containing 1.5 mg/mL collagenase V (C8170; Solarbio) and 62.5 U/mL DNase I (EN0521; Thermo Fisher Scientific). Next, the solution was shaken at 37°C with a constant temperature shaker. The digestion was terminated with precooled HBSS containing 1% FBS when the tissue was visually observed as a fine line, and islets were purified through programmed sedimentation. Finally, isolated islets were handpicked and cultured in RIPM 1640) in 95% air/5% CO2 at 37°C.

Western Blot
INS-1 cells and islets were harvested and lysed in RIPA buffer (Beyotime, China). Protein concentrations were detected with a BCA assay kit (P0012S, Beyotime, Shanghai, China). 20 micrograms of protein were loaded onto the gel. After running on 10% sodium dodecyl sulfate-polyacrylamide gel electrophoresis gels (EpiZyme, China), proteins were transferred to polyvinylidene difluoride membranes (Millipore, Temecula, CA), which were blocked with 5% milk at room temperature for 1 h. Transferred membranes were incubated overnight at 4°C with the following primary antibodies. After incubation with horseradish-peroxidase-labeled secondary antibodies, protein bands were exported by Image Lab software (BioRad, USA). Protein-band intensities were measured via ImageJ and were normalized to b-actin. Primary antibodies are listed in Table 1.

RNA Extraction and Quantitative Real-Time PCR
Total RNA from INS-1 cells was extracted with RNAiso Plus solution (Takara, Japan). Then, 1 ug RNA was reversetranscribed into cDNA using PrimeScriptTM Reverse Transcriptase (Takara, Japan). Real-time PCR was conducted with the SYBR Green PCR kit (Takara, Japan). Relative expression levels of target mRNAs were normalized to b-actin and were calculated based on the 2-DDCt comparative method. Primer sequences are listed in Table 2.

Statistical Analysis
Three independent experiments were performed, and results were expressed as the mean ± the standard error of the mean (SEM). Data were compared using paired Student t-tests or one-way ANOVA followed by Bonferroni tests in GraphPad Prism 8 software (San Diego, CA, USA). P-values determined from different comparisons < 0.05 were considered statistically significant and are indicated as follows: *P < 0.05; **P < 0.01; ***P < 0.001.

JunD Was Activated in Islets of T2DM Mice and PA-Stimulated INS-1 Cells
First, we evaluated the establishment of the T2DM mice model. The body weight and fasting blood glucose were measured once a week. As shown in Figure 1A, the blood glucose of T2DM mice was higher than that of control mice. Meanwhile, the body weights of mice in two groups were measured. The results showed that the body weights of T2DM mice were significantly lower than that of blank controls ( Figure 1B). Glucose homeostasis of T2DM mice was significantly impaired. The IPGTT showed significant and glucose intolerance ( Figure 1C), and the IPITT indicated markedly reduced insulin sensitivity ( Figure 1D) in T2DM mice. The immunofluorescence showed that T2DM mice had a lower insulin-positive cell ratio and a higher glucagon-positive cell ratio ( Figure 1E). We performed body composition analysis by dual-energy X-ray absorptiometry to study the body fat percentage (BFP, %) levels. The results showed that the BFP levels of T2DM mice were dramatically elevated compared with the control group ( Figure 1F). These data suggested that the T2DM mice model was successfully established. In addition, the protein level of JunD in islets of T2DM mice was elevated compared to that of control mice ( Figure 1G), which indicated the activation of JunD. Then we evaluated whether JunD was activated in PAinduced INS-1 cells. PA is widely used to induce lipotoxicity mimicking the environment of T2DM (17). The CCK8 assay was performed to determine the concentration and stimulation time of PA ( Figure S1A). We examined whether 0.4mM PA could activate JunD. We found that the expression of JunD was increased at 6h, and reached its peak at 24h, then gradually decreased ( Figure S1B). As a result, we chose a 0.4 mM PA to stimulate for 24h in the following experiment. The results showed a significant increase in the expressions of JunD in PA-treated INS-1 cells compared with control cells, both at mRNA and protein levels ( Figure 1H). Taken together, these results confirmed the activation of the JunD in islets of T2DM mice and PA-treated INS-1 cells.

PA Induced INS-1 Cells Dysfunction
The TUNEL assay showed that the number of TUNEL-positive INS-1 cells after PA stimulation was dramatically increased compared with blank controls (Figure 2A). Additionally, we examined the protein levels of cleaved-caspase3 and Bax. The results showed that the expressions of cleaved-caspase3 and Bax were increased in PA-induced INS-1 cells, which indicated that the apoptosis of INS-1 cells was increased under PA stimulation ( Figure 2B). Insulin secretion of INS-1 cells was measured by glucose-stimulated insulin secretion (GSIS) after exposure to PA for 24h. The results showed that PA upregulated basal insulin secretion at 2.5mM glucose. However, under the circumstance of 25mM glucose, insulin secretion after PA stimulation was much lower than that of the control group ( Figure 2C). Meanwhile, essential genes for pancreatic b-cells function, such as Pdx1, Nkx6.1, Irs-2, Glut2, and Ucp2 were evaluated. Compared with the control group, the mRNA expressions of Pdx1, Nkx6.1, Irs-2, and Glut2 were significantly reduced after PA stimulation. On the other hand, PA increased Ucp2 mRNA levels in INS-1 cells ( Figure 2D), which inhibits insulin secretion by reducing ATP synthesis (16). Collectively, these findings indicated that lipotoxicity led to the dysfunction of pancreatic b-cells.

PA Induced Lipid Accumulation in INS-1 Cells
We further assessed whether PA could induce lipid accumulation in INS-1 cells. Intracellular lipid accumulation was evaluated by Oil red O staining. As shown in Figure 3A, there were no apparent lipid droplets in the control group. In contrast, after exposure to PA, a large number of lipid droplets were accumulated in the cytoplasm. SREBP1c, a transcription factor responsible for fatty acid synthesis (17), was increased in PAstimulated INS-1 cells ( Figure 3B). The real-time PCR array revealed a profound upregulation of genes implicated in fatty acid synthesis (i.e., Fas, SCD1), uptake (i.e., Cd36, Fabp4), hydrolysis (i.e., Lpl), and storage (i.e., Plin5) after PA stimulation compared to the control group ( Figure 3C). These results indicated that PA stimulated lipid production and led to lipid accumulation in INS-1 cells.  Figures 4A-D). Our results showed that PPARg was increased after PA stimulation, both at protein and mRNA levels ( Figure 5A). JunD depletion downregulated the expressions of PPARg ( Figure 5B), which indicated that PPARg might be the downstream target of JunD. Then we evaluated the function and lipid accumulation of INS-1 cells. The TUNEL assay showed that the number of TUNEL-positive cells was decreased ( Figure 5C), and Western blot showed lower expressions of cleaved-caspase3 and Bax ( Figure 5D) in PA-induced INS-1 cells after transfection with JunD siRNA. As shown in Figure 5E, gene silencing of JunD reversed the impaired GSIS after PA stimulation. Meanwhile, the mRNA levels of Pdx1, Nkx6.1, Irs-2, Glut2, and Ucp2 were also significantly ameliorated ( Figure 5F). The Oil Red O staining showed reduced lipid droplets in JunD-depleted INS-1 cells ( Figure 5G). Depletion of JunD also suppressed the expression of SREBP1c (Figure 5H), as well as the levels of Scd1, Plin5, Lpl, Fas, Cd36, and Fabp4 ( Figure 5I). These results revealed that JunD/PPARg signaling pathway was involved in the dysfunction of INS-1 cells.

DISCUSSION
Pancreas plays a major role in maintaining normal blood glucose levels; however, the islet function of T2DM patients is impaired. Previous studies have shown that metabolic stress leads to the disorder of glucose and lipid metabolisms and finally results in cell dysfunction (18). The dysfunction of pancreatic b-cells is mainly manifested by insufficient secretion, which leads to accelerated progress of diabetes and forms a vicious circle (19); and if without timely intervention, the body will gradually lose weight (20,21), leading to many serious complications. The weight loss is likely to be the result of catabolic effects of insulin deficiency and acidosis (21,22); meanwhile, if T2DM progresses to diabetic nephropathy, osmotic diuresis can also lead to blood volume reduction and weight loss (23). Therefore, restoring the function of pancreatic b-cells is a key node to treat T2DM. Highfat diet combined with STZ was used to mimics T2DM model. High-fat diet is used to simulate the eating habits of most patients with type 2 diabetes (24), and STZ helps to destroy the function of b cells (25). The expansion of adipose tissue releases a large amounts of nonesterified fatty acids, such as oleic acid and PA (26). PA induces insulin resistance and pancreatic b-cells dysfunction via three mechanisms (27): (1) Increased internalization of palmitic acid results in lipotoxicity (28); (2) The excess of PA results in the endoplasmic reticulum and mitochondria dysfunction (29,30); (3) PA can activate toll-like receptor (TLR)-4 and high-fat diets activate the IKKb-NF-kB pathway, leading to an inflammatory environment (31,32). Here, we revealed the important role of JunD in pancreatic bcells by altering lipid accumulation.
The causes of pancreatic b-cells dysfunction include ectopic lipid accumulation, which leads to oxidative stress, inflammation, and b-cell apoptosis (33). Even more notably, improving b-cell lipid metabolism could boost the regeneration of b-cells (34). Therefore, it is important to decipher the The mRNA levels of TGsynthesis, uptake, hydrolysis, and storage-related genes, including Fas, Scd1, Cd36, Fabp4, Lpl, and Plin5. Data are expressed as the mean ± SEM. **p < 0.01; ***p < 0.001 (compared with control group). mechanism of lipid deposition in b cells. Most of the studies focus on the disorder of lipid synthesis, transport, hydrolysis, and storage. Estrogen receptors and liver X receptors are both expressed in pancreatic b-cells and regulate genes related to lipid metabolisms, such as Fas, Acc, and Cpt1a (35,36). Autophagy is a lysosomal-dependent cellular catabolism mechanism and decreases cellular lipid stores in pancreatic bcells (37). Adipose triglyceride lipase is responsible for lipid droplet mobilization in human b-cells (38). However, the researches on the lipid metabolism of b-cells are still insufficient and there are few targeted treatments.
Recently, JunD has emerged as a vital player in the setting of metabolic diseases (11)(12)(13)(14)40). Hyperglycemia promotes ROS production by downregulating JunD expression, which leads to cardiac dysfunction. In addition, previous studies have indicated that the impact of JunD in metabolic cardiomyopathy and NAFLD is mainly caused by promoting intracellular lipid deposition through the PPARg signaling pathway. JunD−/− mice showed reduced intra-myocardial TG accumulation, total liver, and fat pad weights (13,14). Besides, the cardiac specimens of obese patients had higher expression of JunD, as well as TGrelated genes vs. non-obese hearts (13). These researches indicated that JunD is an upstream regulator of PPARg and mediates the transcription of genes involved in lipid uptake, hydrolysis, and storage.
JunD also acts as a stress-responsive factor that induces redox imbalance and apoptosis in pancreatic b-cells (12). However, it will be of interest to determine whether JunD is involved in the  (46). Peroxisome-generated hydrogen peroxide mediates the lipotoxicity in pancreatic bcells, which might be the potential mechanism of b cell dysfunction caused by PPARg activation (47). Under pathological states, such as high glucose and obesity, the activation of PPARg in pancreatic b-cells might aggravates apoptosis and affect glucose homeostasis (48).
It is unclear whether other mechanisms are contributing to the regulation of JunD in GSIS. Mitochondrial dysfunction (49), ER stress (50), as well as imbalance of Ca2+ homeostasis (51) are associated with pancreatic b-cells dysfunction. Mitochondrial dysfunction including changed mitochondrial structure, decreased mitochondrial respiration, reduced mitochondrial ATP production (52). Akhmedov  cardiomyocyte-specific JunD overexpression reduced Sirt3 transcription, thus leading to mitochondrial dysfunction (53).
Our results showed that JunD reversed the increase of Ucp2 induced by PA, which inhibits insulin secretion by reducing ATP synthesis (16), indicating that JunD might improve GSIS by changing mitochondrial ATP production. Good et al. found that the depletion of JunD downregulated Ptgs2 in db/db mice, which encodes cyclooxygenase-2 (COX2) and imparts insulin secretion of pancreatic b-cells (12).
genes (56). Human amylin could activate the expression of c-jun, mediate the combination of c-jun with c-fos or ATF-2, and activate the downstream apoptosis pathway of pancreatic b-cells (57). Gurzov et al. indicated that JunB plays a protective role against apoptosis in pancreatic b-cells through inhibiting iNOS and Chop expression (58). Meanwhile, an inflammatory environment upregulates JunB/ATF3 pathway and protects b cells by increasing cAMP expression (59).
Taken together, our research provides a new strategy for restoring the function of pancreatic b-cells and has a prospect of clinical treatment.

DATA AVAILABILITY STATEMENT
The original contributions presented in the study are included in the article/Supplementary Material. Further inquiries can be directed to the corresponding authors.

ETHICS STATEMENT
The animal study was reviewed and approved by Shandong University.

AUTHOR CONTRIBUTIONS
KXW, YXC, and ZNY were involved in study design, interpreting data, statistical analysis, creating tables and figures, and writing the manuscript. KXW, PL, and YS were involved in interpreting data, statistical analysis, and designed the research, supervised the work. All authors contributed to the article and approved the submitted version.